Chaubey Alka 4
4 · Bionano Genomics, Inc. · Filed Jun 3, 2026
Research Summary
AI-generated summary of this filing
Bionano (BNGO) CMO Alka Chaubey: Shares Withheld for Taxes (24)
What Happened
Alka Chaubey, Chief Medical Officer of Bionano Genomics (BNGO), had 24 shares of common stock withheld by the issuer to satisfy tax withholding obligations when RSUs vested. The withholding was reported as a disposal of 24 shares at $1.30 per share, for a total value of $31. This was a tax-withholding settlement of vested restricted stock units (not an open-market sale).
Key Details
- Transaction date and price: June 3, 2026; 24 shares withheld at $1.30 per share (total $31).
- Shares owned after transaction: Not specified in the provided excerpt.
- Footnote: The 24 shares were withheld to satisfy tax withholding on RSUs that vested on June 3, 2026 from an award granted June 3, 2024.
- Transaction code and meaning: Code F — payment of exercise price or tax liability (share withholding).
- Filing timeliness: Reported on June 3, 2026 (same day as the transaction), indicating a timely filing.
Context
This is a routine cashless/withholding settlement of vested RSUs and does not reflect an active market sale or purchase by the insider. Such withholdings are common when equity awards vest and are generally administrative — they are not typically interpreted as a directional insider trade signal.
Insider Transaction Report
- Tax Payment
Common Stock
[F1]2026-06-03$1.30/sh−24$31→ 620 total
Footnotes (1)
- [F1]The reporting person is reporting the withholding by the Issuer of an aggregate of 24 shares of common stock in connection with shares that vested on June 3, 2026 pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award.